ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

DCT To Announce June 1 Guidelines For CREG Program In Cell Kinetics Related To Chemo, Radiotherapy

April 25, 1975

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

Talpin To Join NCI

June 27, 2003

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998

Rimer, Boxer Reappointed to NCAB; 4 Others Named

June 28, 1996

In Brief: alberts elected To Second Term as NAS President

February 19, 1999